Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Taitong Pharmaceutical is a major manufacturer of plant-based active pharmaceutical ingredients (APIs), specializing in rutin APIs and related plant extracts. The company is recognized as the world's largest producer of rutin, derived from Sophora japonica (Chinese scholar tree), and also produces monoammonium glycyrrhizinate, dipotassium glycyrrhizinate, and L-rhamnose from natural sources. Its products are used in pharmaceutical, food additive, cosmetic, and supplemental applications, targeting capillary contraction, hemostasis, hypertension, inflammation, and liver protection. The company maintains a strong export presence, especially to Europe and Japan[4][6][13].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tai Tong Pharmaceutical.